<p><strong>Plaque Psoriasis-</strong><br />
<br />
1. Recommended dosage is 300 mg by subcutaneous injection at Weeks 0, 1, 2, 3, and 4 followed by 300 mg every 4 weeks. For some patients, a dose of 150 mg may be acceptable.<br />
<br />
<strong>Psoriatic Arthritis-</strong><br />
<br />
1. For psoriatic arthritis patients with coexistent moderate to severe plaque psoriasis, use the dosage and administration for plaque psoriasis.<br />
<br />
2. For other psoriatic arthritis patients administer with or without a loading dosage. The recommended dosage:</p>

<ul>
	<li>With a loading dosage is 150 mg at weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter</li>
	<li>Without a loading dosage is 150 mg every 4 weeks</li>
	<li>If a patient continues to have active psoriatic arthritis, consider a dosage of 300 mg.</li>
</ul>

<p><br />
<strong>Ankylosing Spondylitis-</strong><br />
<br />
1. Administer with or without a loading dosage. The recommended dosage:</p>

<ul>
	<li>With a loading dosage is 150 mg at weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter</li>
	<li>Without a loading dosage is 150 mg every 4 weeks</li>
</ul>